We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Device Panelists’ Trial Critiques Are Killing Companies, Critics Say
Device Panelists’ Trial Critiques Are Killing Companies, Critics Say
October 14, 2011
Device innovation is suffering because FDA conflict of interest rules keep experienced and insightful practitioners from serving on advisory panels, industry and lawmakers say.